Radiation Retinopathy Is Treatable With Anti–Vascular Endothelial Growth Factor Bevacizumab (Avastin)

Published in: International Journal of Radiation Oncology*Biology*Physics

Volume 70, Issue 4, pp. 974-977

DOI: 10.1016/j.ijrobp.2007.11.045